Summit Therapeutics Inc banner

Summit Therapeutics Inc
NASDAQ:SMMT

Watchlist Manager
Summit Therapeutics Inc Logo
Summit Therapeutics Inc
NASDAQ:SMMT
Watchlist
Price: 16.33 USD 3.88% Market Closed
Market Cap: $12.7B

Wall Street
Price Targets

SMMT Price Targets Summary
Summit Therapeutics Inc

Wall Street analysts forecast SMMT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMMT is 33.08 USD with a low forecast of 12.12 USD and a high forecast of 44.1 USD.

Lowest
Price Target
12.12 USD
26% Downside
Average
Price Target
33.08 USD
103% Upside
Highest
Price Target
44.1 USD
170% Upside
Summit Therapeutics Inc Competitors:
Price Targets
HCAT
Health Catalyst Inc
117% Upside
PTGX
Protagonist Therapeutics Inc
6% Upside
TELA
TELA Bio Inc
318% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SMMT's stock price target?
Price Target
33.08 USD

According to Wall Street analysts, the average 1-year price target for SMMT is 33.08 USD with a low forecast of 12.12 USD and a high forecast of 44.1 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett